Literature DB >> 13123588

Chlorpromazine; new inhibiting agent for psychomotor excitement and manic states.

H E LEHMANN, G E HANRAHAN.   

Abstract

Entities:  

Keywords:  AUTONOMIC DRUGS/therapeutic use; PSYCHOSES, MANIC-DEPRESSIVE/therapy

Mesh:

Substances:

Year:  1954        PMID: 13123588

Source DB:  PubMed          Journal:  AMA Arch Neurol Psychiatry        ISSN: 0096-6886


× No keyword cloud information.
  43 in total

1.  Liver damage and eosinophilia following chlorpromazine therapy; report of a case.

Authors:  B S HARTNETT
Journal:  Br Med J       Date:  1955-06-18

2.  Chlorpromazine in the treatment of mental illness. V. Administrative problems.

Authors:  H C DENBER; J H TRAVIS
Journal:  Psychiatr Q       Date:  1958-07

3.  [The effect of reserpine and megaphen on the galvanic skin reflex and on EEG].

Authors:  R AHRENS; H RADTKE
Journal:  Acta Neuroveg (Wien)       Date:  1958

4.  Tranquillizers and other psychotropic drugs in clinical practice.

Authors:  H E LEHMANN
Journal:  Can Med Assoc J       Date:  1958-11-01       Impact factor: 8.262

5.  The response of chronically hospitalized, lobotomized patients to treatment with chlorpromazine and reserpine.

Authors:  A A KURLAND; T G WILLIAMS; T E HANLON
Journal:  Psychiatr Q       Date:  1959-10

6.  Comparison of the effects of promazine and chlorpromazine in mental syndromes.

Authors:  H AZIMA; H DUROST
Journal:  Can Med Assoc J       Date:  1957-10-01       Impact factor: 8.262

7.  Chlorpromazine jaundice in a general hospital.

Authors:  G S GRAHAM
Journal:  Br Med J       Date:  1957-11-09

8.  Effects of promazine in mental syndromes.

Authors:  H AZIMA; H DUROST
Journal:  Can Med Assoc J       Date:  1957-03-15       Impact factor: 8.262

9.  Liver damage following the use of chlorpromazine (thorazine).

Authors:  N MITCHELL; C WILKINSON
Journal:  J Natl Med Assoc       Date:  1956-01       Impact factor: 1.798

10.  The occurrence of epileptic fits in leucotomized patients receiving chlorpromazine therapy.

Authors:  D W LIDDELL; N RETTERSTOL
Journal:  J Neurol Neurosurg Psychiatry       Date:  1957-05       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.